Competent dendritic cells derived from CD34+ progenitors express CMRF-44 antigen early in the differentiation pathway

Immunology and Cell Biology

Volumn 80, Issue 3, 2002, Pages 216-225

  Monji, Tatsue ^a   Petersons, Jerilyn Tynes ^a   Saund, Narinder K ^a   Vuckovic, Slavica ^b   Hart, Derek Nigel John ^b   Auditore Hargreaves, Karen ^a   Risdon, Grant ^a  

^a Cell Pro Inc   (United States)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

CD34+; CMRF 44; Dendritic cell; Differentiation; Th1 responses

Indexed keywords

ANTIGEN; CD34 ANTIGEN; CD40 ANTIGEN; CMRF 44 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETANUS TOXIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL SELECTION; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LEUKAPHERESIS; STEM CELL; CHEMISTRY; GENETICS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMAN; INTERLEUKIN-4; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; STEM CELLS; TUMOR NECROSIS FACTOR; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035989326     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2002.01075.x     Document Type: Article

References (52)

1. The dendritic cell system and its role in immunogenicity
2. Primary stimulation by dendritic cells induces anti-viral proliferative and cytotoxic T cell responses in vitro
3. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
4. + T cell lines from naive precursors
5. Dendritic cells stimulate primary human cytolytic lymphocytes in the absence of CD4+ helper T cells
6. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro
7. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells
8. Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin
9. + progenitors in human bone marrow
10. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumour necrosis factor-a
11. A skin homing molecule defines the Langerhans cell progenitor in human peripheral blood
12. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population
13. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production
14. Human T, B, natural killer and dendritic cells arise from a common bone marrow progenitor cell subset
15. A new monoclonal antibody (IE8) reactive with dendritically shaped cells in the human tonsil
16. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily
17. Characterisation of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells
18. Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: Implications for studies on antigen presenting cell function and immunotherapy
19. Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype
20. + bone marrow progenitors that are expanded by c-kit ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-a
21. + blood progenitors for anticancer therapy
22. + hematopoeitic progenitor cells in serum-free medium
23. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors
24. Positive selection of lymphocyte subsets using the ceprate system: Evaluation of in vitro functional activity
25. GM-CSF and TNF-a cooperate in the generation of dendritic Langerhans cells
26. Identification of a novel cell type in peripheral lymphoid organs of mice morphology, quantitation; tissue distribution
27. TNFa in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages
28. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development
29. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with GM-CSF
30. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
31. Endogenously produced interleukin 6 is an accessory cytokine for dendritic cell hematopoiesis
32. Interleukin-6 and its receptor: A paradigm for cytokines
33. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells
34. Proliferating dendritic cell progenitors in human blood
35. Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow
36. Tumor necrosis factor-a maintains the viability of murine epidermal Langerhans cells in culture but in contrast to granulocyte/macrophage colony-stimulatory factor, does not induce their functional maturation
37. Human keratinocytes are a source for tumor necrosis factor alpha. Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light
38. Absence of B7-dependent responses in CD28-deficient mice
39. CD28/B7 system of T cell costimulation
40. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines
41. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28
42. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
43. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones
44. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
45. Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
46. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells
47. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
48. + T lymphocytes by human blood DC in vitro
49. Activation of human dendritic cells through CD40 cross-linking
50. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway
51. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal
52. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway